These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33911345)

  • 1. MicroRNA-384 inhibits nasopharyngeal carcinoma growth and metastasis via binding to Smad5 and suppressing the Wnt/β-catenin axis.
    Zeng X; Liao H; Wang F
    Cytotechnology; 2021 Apr; 73(2):203-215. PubMed ID: 33911345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4.
    Hu H; Wang G; Li C
    Onco Targets Ther; 2017; 10():2711-2720. PubMed ID: 28579809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma.
    Zheng YJ; Zhao JY; Liang TS; Wang P; Wang J; Yang DK; Liu ZS
    FASEB J; 2019 Nov; 33(11):12915-12928. PubMed ID: 31557058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.
    Zhang Y; Zhang H; Li X
    J BUON; 2020; 25(3):1579-1586. PubMed ID: 32862607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y; Wang M; Li X; Cui F
    Yonsei Med J; 2019 Apr; 60(4):336-345. PubMed ID: 30900419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma via microRNA-195-Dependent Inhibition of SMAD5.
    Li S; Zhao B; Zhao H; Shang C; Zhang M; Xiong X; Pu J; Kuang B; Deng G
    Front Oncol; 2019; 9():1246. PubMed ID: 31921616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.
    Zhao CC; Jiao Y; Zhang YY; Ning J; Zhang YR; Xu J; Wei W; Kang-Sheng G
    Cell Death Dis; 2019 Mar; 10(4):252. PubMed ID: 30874550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-574-5p Targets FOXN3 to Regulate the Invasion of Nasopharyngeal Carcinoma Cells via Wnt/β-Catenin Pathway.
    Lin Z; Chen M; Wan Y; Lei L; Ruan H
    Technol Cancer Res Treat; 2020; 19():1533033820971659. PubMed ID: 33317407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CBP/β-Catenin Antagonist, ICG-001, Inhibits Tumor Metastasis via Blocking of the miR-134/ITGB1 Axis-Mediated Cell Adhesion in Nasopharyngeal Carcinoma.
    Chen L; Chiang YC; Chan LS; Chau WY; Lung ML; Kahn M; Lo KW; Mak NK; Lung HL
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
    Zhang J; Wen X; Ren XY; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Sun Y; Liu N; Ma J
    J Exp Clin Cancer Res; 2016 Jul; 35(1):109. PubMed ID: 27400785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-103 promotes nasopharyngeal carcinoma through targeting TIMP-3 and the Wnt/β-catenin pathway.
    Zhao Y; Gu X; Wang Y
    Laryngoscope; 2020 Mar; 130(3):E75-E82. PubMed ID: 31038780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis.
    Cheng C; Li W; Peng X; Liu X; Zhang Z; Liu Z; Deng T; Luo R; Fang W; Deng X
    Mol Ther Methods Clin Dev; 2021 Mar; 20():615-624. PubMed ID: 33718512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-122-5p promotes peritoneal fibrosis in a rat model of peritoneal dialysis by targeting Smad5 to activate Wnt/β-catenin pathway.
    Liu Y; Ma Z; Huang Z; Zou D; Li J; Feng P
    Ren Fail; 2022 Dec; 44(1):191-203. PubMed ID: 35170385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-4429 suppresses proliferation of prostate cancer cells by targeting distal-less homeobox 1 and inactivating the Wnt/β-catenin pathway.
    Wang J; Xie S; Liu J; Li T; Wang W; Xie Z
    BMC Urol; 2021 Mar; 21(1):40. PubMed ID: 33740948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.
    Zhang T; Lei F; Jiang T; Xie L; Huang P; Li P; Huang Y; Tang X; Gong J; Lin Y; Cheng A; Huang W
    Curr Mol Pharmacol; 2019; 12(4):324-333. PubMed ID: 31677258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
    Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
    J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
    Ren W; Wang D; Li C; Shu T; Zhang W; Fu X
    Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Yang Z; Ye X; Zhang Y; Huang Y; Chen J; Zeng Y; Chen J
    Cytotechnology; 2022 Apr; 74(2):231-243. PubMed ID: 35464163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.